The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2340 participants.
Also called NCT06757764
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,340 participants
- Registry
-
NCT06757764
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06757764. Randomized; triple masking; primary purpose treatment. Start 2025-07-10 (actual); primary completion 2028-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
- Acronym
- CHANGE
- Condition
- Cerebral Infarction
- Condition
- Stenosis Artery
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Asan Medical Center
- Collaborator
- Korea Otsuka Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct06757764- Content hash
9b2737ad3868718274049e2b11fc82223fcc1b5b61663fa418d4bf13d858d453